RVPH: Reviva Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 91.01
Enterprise Value ($M) 67.65
Book Value ($M) 5.72
Book Value / Share 0.20
Price / Book 15.92
NCAV ($M) 5.72
NCAV / Share 0.20
Price / NCAV 15.92

Profitability (mra)
Return on Invested Capital (ROIC) -6.87
Return on Assets (ROA) -3.04
Return on Equity (ROE) -6.79

Liquidity (mrq)
Quick Ratio 1.38
Current Ratio 1.38

Balance Sheet (mrq) ($M)
Current Assets 23.70
Assets 23.70
Liabilities 17.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -39.50
Net Income -39.26
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.32
Cash from Investing 0.00
Cash from Financing 33.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13D/A Bhat Laxminarayan 10.20 2.64
02-14 13G Armistice Capital, Llc 6.32
02-14 13G/A Tang Capital Partners Lp 9.99 36.73
11-30 13D/A Vedanta Partners, Llc 19.90 5.59

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 20,984 84,686 24.78
2024-05-01 13,785 28,612 48.18
2024-04-30 33,823 18,864 179.30
2024-04-29 30,466 40,809 74.66

(click for more detail)

Similar Companies
RMTI – Rockwell Medical, Inc. RNAZ – TransCode Therapeutics, Inc.
RNXT – RenovoRx, Inc. RZLT – Rezolute, Inc.
SABS – SAB Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io